Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis (Q38160536)

30 August 2017

title

Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis (English)

1 reference

30 August 2017

0 references

Ronen Ben-Ami

1

1 reference

30 August 2017

publication date

1 November 2013

1 reference

30 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

30 August 2017

volume

8

1 reference

30 August 2017

issue

11

1 reference

30 August 2017

page(s)

1453-1462

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

30 August 2017

1 reference

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Fungal adaptation to the mammalian host: it is a new world, after all.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Hypoxia and fungal pathogenesis: to air or not to air?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Oxygen requirements of Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Reduced nicotinamide adenine dinucleotide phosphate oxidase-independent resistance to Aspergillus fumigatus in alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Aspergillus fumigatus: virulence genes in a street-smart mold

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Identification of genes of Aspergillus fumigatus up-regulated during growth on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Aspergillus fumigatus stimulates leukocyte adhesion molecules and cytokine production by endothelial cells in vitro and during invasive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Regulation of angiogenesis by oxygen and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Redox signaling of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Fungal secondary metabolism - from biochemistry to genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Anti-angiogenic activities of gliotoxin and its methylthioderivative, fungal metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Pyripyropenes, fungal sesquiterpenes conjugated with alpha-pyrone and pyridine moieties, exhibits anti-angiogenic activity against human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

LaeA, a regulator of morphogenetic fungal virulence factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Transcriptional regulation of chemical diversity in Aspergillus fumigatus by LaeA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Sub-telomere directed gene expression during initiation of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Discovery of gliotoxin as a new small molecule targeting thioredoxin redox system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Gliotoxin induces apoptosis in cultured macrophages via production of reactive oxygen species and cytochrome c release without mitochondrial depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Detection of gliotoxin in experimental and human aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Angiogenesis: a potentially critical part of remodelling in chronic airway diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Aspergillosis. Pathogenesis, clinical manifestations, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Lung transplant airway hypoxia: a diathesis to fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Enhancing angiogenesis in invasive aspergillosis: a novel therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Angiogenesis in acute myeloid leukemia and opportunities for novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

The damage-response framework of microbial pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.13.114

Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1309/UJRV9DLC11RM3G8R

Identifiers

DOI

10.2217/FMB.13.114

1 reference

30 August 2017

1 reference